NSD2 Gene

Name nuclear receptor binding SET domain protein 2
Description This gene encodes a protein that contains four domains present in other developmental proteins: a PWWP domain, an HMG box, a SET domain, and a PHD-type zinc finger. It is expressed ubiquitously in early development. Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4. This gene maps to the 165 kb WHS critical region and has also been involved in the chromosomal translocation t(4;14)(p16.3;q32.3) in multiple myelomas. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Some transcript variants are nonsense-mediated mRNA (NMD) decay candidates, hence not represented as reference sequences. [provided by RefSeq, Jul 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNSD2 is a multidomain histone methyltransferase that orchestrates chromatin architecture and gene‐regulatory programs by catalyzing methylation on key lysine residues of histones—including dimethylation of histone H3 lysine 36 (H3K36me2), methylation of H4K20, and even activity toward H3K4—in a context‐dependent manner. Its catalytic activity not only reprograms the overall chromatin landscape but also creates binding surfaces for downstream effectors (for example, by facilitating recruitment of 53BP1 at DNA double‐strand breaks), thereby integrating epigenetic signals with the DNA damage response and developmental programs. This epigenetic reprogramming is mediated by its interplay with other chromatin regulators and is essential for proper transcriptional control and chromatin organization during normal development and in response to genotoxic stress."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDysregulation of NSD2—frequently resulting from chromosomal translocations, gene amplification or point mutations—leads to its overexpression in a wide array of cancers such as multiple myeloma, prostate cancer, lung adenocarcinoma, neuroblastoma, osteosarcoma and even certain solid tumors. Aberrant NSD2 activity induces widespread epigenomic reorganization characterized by altered patterns of H3K36me2 and antagonistic H3K27me3, among other marks, which in turn drive oncogenic transcriptional programs involved in cellular proliferation, adhesion, migration, invasion, and even the epithelial–mesenchymal transition. Moreover, NSD2‐mediated chromatin changes contribute to defective DNA repair and chemoresistance, forging a link between its epigenetic function and malignant progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent mechanistic studies have illuminated the structural basis for NSD2’s substrate recognition and its interplay with chromatin‐associated factors. High‐resolution analyses, including cryo–electron microscopy and quantum chemical modeling of its catalytic transition state, have provided insights into how NSD2 binds nucleosomes and selectively installs methyl marks—a process that may be disrupted by cancer‐associated mutations. In parallel, efforts to target key domains of NSD2 (both its SET catalytic domain and its chromatin–reader modules) have underscored its potential as a therapeutic target to overcome NSD2‐driven oncogenic signaling and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "35", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Madhumita Santra, Fenghuang Zhan, Erming Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-09-2801"}], "href": "https://doi.org/10.1182/blood-2002-09-2801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12433679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12433679"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-09-3704"}], "href": "https://doi.org/10.1182/blood-2004-09-3704"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15677557"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15677557"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sung Mi Kim, Hae Jin Kee, Gwang Hyeon Eom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of a novel WHSC1-associated SET domain protein with H3K4 and H3K27 methyltransferase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.04.095"}], "href": "https://doi.org/10.1016/j.bbrc.2006.04.095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16682010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16682010"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Josh Lauring, Abde M Abukhdeir, Hiroyuki Konishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-05-088674"}], "href": "https://doi.org/10.1182/blood-2007-05-088674"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17942756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17942756"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jotin Marango, Manabu Shimoyama, Hitomi Nishio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-06-092122"}], "href": "https://doi.org/10.1182/blood-2007-06-092122"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18156491"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18156491"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ji-Young Kim, Hae Jin Kee, Nak-Won Choe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.02130-07"}], "href": "https://doi.org/10.1128/MCB.02130-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18172012"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18172012"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jie Li, Chunyue Yin, Hiroaki Okamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuro Oncol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1215/15228517-2007-036"}], "href": "https://doi.org/10.1215/15228517-2007-036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18182627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18182627"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jose L R Brito, Brian Walker, Matthew Jenner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3324/haematol.13426"}], "href": "https://doi.org/10.3324/haematol.13426"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19059936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19059936"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Eva Martinez-Garcia, Relja Popovic, Dong-Joon Min, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-07-298349"}], "href": "https://doi.org/10.1182/blood-2010-07-298349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20974671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20974671"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Huadong Pei, Lindsey Zhang, Kuntian Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature09658"}], "href": "https://doi.org/10.1038/nature09658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21293379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21293379"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Heidi Rye Hudlebusch, Eric Santoni-Rugiu, Ronald Simon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-10-1302"}], "href": "https://doi.org/10.1158/1078-0432.CCR-10-1302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21385930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21385930"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Heidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMSET is highly expressed and associated with aggressiveness in neuroblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-3810"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-3810"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21527557"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21527557"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ildiko Hajdu, Alberto Ciccia, Susanna M Lewis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Wolf-Hirschhorn syndrome candidate 1 is involved in the cellular response to DNA damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1110081108"}], "href": "https://doi.org/10.1073/pnas.1110081108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21788515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21788515"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Gouji Toyokawa, Hyun-Soo Cho, Ken Masuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.11048"}], "href": "https://doi.org/10.1593/neo.11048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22028615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22028615"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Alex J Kuo, Peggie Cheung, Kaifu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2011.08.042"}], "href": "https://doi.org/10.1016/j.molcel.2011.08.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22099308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22099308"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ping Yang, Linlang Guo, Zhijian J Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00204-12"}], "href": "https://doi.org/10.1128/MCB.00204-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22645312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22645312"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Liang Chu, Mack Y Su, Leonard B Maggi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI63051"}], "href": "https://doi.org/10.1172/JCI63051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22751105"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22751105"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "T Ezponda, R Popovic, M Y Shah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.297"}], "href": "https://doi.org/10.1038/onc.2012.297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22797064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22797064"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "D-J Min, T Ezponda, M K Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/leu.2012.269"}], "href": "https://doi.org/10.1038/leu.2012.269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22972034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22972034"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Irfan A Asangani, Bushra Ateeq, Qi Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2012.10.008"}], "href": "https://doi.org/10.1016/j.molcel.2012.10.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23159737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23159737"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Huadong Pei, Xiaosheng Wu, Tongzheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone methyltransferase MMSET regulates class switch recombination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1201811"}], "href": "https://doi.org/10.4049/jimmunol.1201811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23241889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23241889"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Erica F Andersen, John C Carey, Dawn L Earl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2013.192"}], "href": "https://doi.org/10.1038/ejhg.2013.192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23963300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23963300"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Vassiliki Saloura, Hyun-Soo Cho, Kazuma Kiyotani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-14-0292-T"}], "href": "https://doi.org/10.1158/1541-7786.MCR-14-0292-T"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25280969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25280969"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Masayo Morishita, Damiaan Mevius, Eric di Luccio "}, {"type": "b", "children": [{"type": "t", "text": "In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Struct Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12900-014-0025-x"}], "href": "https://doi.org/10.1186/s12900-014-0025-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25494638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25494638"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Theodore Vougiouklakis, Ryuji Hamamoto, Yusuke Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The NSD family of protein methyltransferases in human cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi.15.32"}], "href": "https://doi.org/10.2217/epi.15.32"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25942451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25942451"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Saumya M Sankaran, Alex W Wilkinson, Joshua E Elias, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.720748"}], "href": "https://doi.org/10.1074/jbc.M116.720748"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26912663"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26912663"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "M Y Shah, E Martinez-Garcia, J M Phillip, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2016.116"}], "href": "https://doi.org/10.1038/onc.2016.116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27109101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27109101"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Junjian Wang, Zhijian Duan, Zoann Nugent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2016.05.004"}], "href": "https://doi.org/10.1016/j.canlet.2016.05.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27164560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27164560"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Verónica García-Carpizo, Jacinto Sarmentero, Bomie Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep32952"}], "href": "https://doi.org/10.1038/srep32952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27604143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27604143"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Suraj Peri, Evgeny Izumchenko, Adrian D Schubert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-01877-7"}], "href": "https://doi.org/10.1038/s41467-017-01877-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29176703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29176703"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jin Woo Park, Yun-Cheol Chae, Ji-Young Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0393-y"}], "href": "https://doi.org/10.1038/s41388-018-0393-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30013191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30013191"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Alok Swaroop, Jon A Oyer, Christine M Will, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0474-y"}], "href": "https://doi.org/10.1038/s41388-018-0474-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30171259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30171259"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Nicole J Boczek, Carrie A Lahner, Thuy-Mi Nguyen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.40498"}], "href": "https://doi.org/10.1002/ajmg.a.40498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30345613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30345613"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Alvaro Aytes, Arianna Giacobbe, Antonina Mitrofanova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD2 is a conserved driver of metastatic prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-07511-4"}], "href": "https://doi.org/10.1038/s41467-018-07511-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30518758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30518758"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Wanqiu Li, Wei Tian, Gang Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-020-03069-8"}], "href": "https://doi.org/10.1038/s41586-020-03069-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33361816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33361816"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jing Liu, Ying Xie, Jing Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-21386-y"}], "href": "https://doi.org/10.1038/s41467-021-21386-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33589584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33589584"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Da Song, Jingqin Lan, Yaqi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-021-01747-z"}], "href": "https://doi.org/10.1038/s41388-021-01747-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33742125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33742125"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Deepanwita Sengupta, Liyong Zeng, Yumei Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2021.08.034"}], "href": "https://doi.org/10.1016/j.molcel.2021.08.034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34555356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34555356"}]}]}]}
NCBI Gene ID 7468
API
Download Associations
Predicted Functions View NSD2's ARCHS4 Predicted Functions.
Co-expressed Genes View NSD2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View NSD2's ARCHS4 Predicted Functions.

Functional Associations

NSD2 has 5,834 functional associations with biological entities spanning 5 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 48 datasets.

Click the + buttons to view associations for NSD2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NSD2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of NSD2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Proteomics Cell lines associated with NSD2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with NSD2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of NSD2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with NSD2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of NSD2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing NSD2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing NSD2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with NSD2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of NSD2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by NSD2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for NSD2 protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving NSD2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with NSD2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with NSD2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with NSD2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with NSD2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GO Biological Process Annotations 2023 biological processes involving NSD2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving NSD2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing NSD2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing NSD2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by NSD2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by NSD2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of NSD2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with NSD2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of NSD2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of NSD2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving NSD2 protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of NSD2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of NSD2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by NSD2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MW Enzyme Metabolite Associations interacting metabolites for NSD2 protein from the MW Gene Metabolite Associations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of NSD2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving NSD2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving NSD2 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving NSD2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NSD2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NSD2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of NSD2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of NSD2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of NSD2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of NSD2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of NSD2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NSD2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NSD2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with NSD2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving NSD2 protein from the WikiPathways Pathways 2024 dataset.